Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Emrelis. Always confirm against the full prescribing information.
100 interactions
Abatacept
The metabolism of Telisotuzumab vedotin can be increased when combined with Abatacept.
Level 1 evidence
Adalimumab
The metabolism of Telisotuzumab vedotin can be increased when combined with Adalimumab.
Level 1 evidence
Amiodarone
The serum concentration of MMAE, an active metabolite of Amiodarone, can be increased when used in combination with Telisotuzumab vedotin.
Level 1 evidence
Anakinra
The metabolism of Telisotuzumab vedotin can be increased when combined with Anakinra.
Level 1 evidence
Apalutamide
The serum concentration of Telisotuzumab vedotin can be decreased when it is combined with Apalutamide.
Level 1 evidence
Apremilast
The metabolism of Telisotuzumab vedotin can be increased when combined with Apremilast.
Level 1 evidence
Aprepitant
The metabolism of Telisotuzumab vedotin can be decreased when combined with Aprepitant.
Level 2 evidence
Armodafinil
The metabolism of Telisotuzumab vedotin can be increased when combined with Armodafinil.
Level 2 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Telisotuzumab vedotin is combined with Articaine.
Level 1 evidence
Atazanavir
The serum concentration of MMAE, an active metabolite of Atazanavir, can be increased when used in combination with Telisotuzumab vedotin.
Level 1 evidence
Avanafil
The serum concentration of Avanafil can be increased when it is combined with Telisotuzumab vedotin.
Level 1 evidence
Beclomethasone dipropionate
The metabolism of Telisotuzumab vedotin can be increased when combined with Beclomethasone dipropionate.
Level 2 evidence
Enter your NPI to unlock 7 major interactions for Emrelis
Emrelis (Telisotuzumab Vedotin) has 443 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Emrelis (Telisotuzumab Vedotin) has 38 major, 142 moderate, and 263 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Emrelis. Always confirm against the full prescribing information.